Topic

Aetna (CVS Health)

A collection of 1351 issues

Myths vs. Facts: Getting Orladeyo (berotralstat) Covered by Aetna (CVS Health) in North Carolina

Answer Box: Get Orladeyo (berotralstat) Covered by Aetna (CVS Health) in North Carolina Eligibility: Adults and pediatric patients ≥12 years with confirmed hereditary angioedema (HAE) requiring prophylaxis. Fastest path: Have your HAE specialist submit prior authorization with C1-INH testing, attack documentation, and failed alternatives. First step today: Call Aetna at

Renewing Exondys 51 (Eteplirsen) Approval with Aetna in Georgia: 2025 Requirements, Timeline & Appeal Guide

Quick Answer: Renewing Your Exondys 51 Coverage Start your Exondys 51 renewal 60-90 days before expiration. Aetna requires documented clinical benefit, adherence records, updated cardiac/respiratory function tests, and specialist oversight. If denied, you have 65 days to appeal in Georgia, with expedited 72-hour reviews available for urgent cases. Submit

How Long Does It Take to Get Procysbi Approved by Aetna (CVS Health) in Pennsylvania? Timeline & Appeal Guide

Answer Box: Procysbi Approval Timeline in Pennsylvania Aetna (CVS Health) typically approves over 95% of eligible prior authorizations within 24 hours, though Procysbi requires specialty drug documentation. In Pennsylvania, you have strong appeal rights: the state's Independent External Review Program overturns about 50% of denials. First step today:

How to Get Mavenclad (Cladribine Tablets) Covered by Aetna CVS Health in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Mavenclad Covered by Aetna CVS Health in Illinois Aetna CVS Health requires prior authorization (PA) for Mavenclad (cladribine tablets) in Illinois, with approval typically taking 72 hours when you meet their criteria: confirmed relapsing MS, documented failure of ≥2 disease-modifying therapies (DMTs), lymphocyte count ≥800 cells/μL,

How to Get Gattex (Teduglutide) Approved by Aetna (CVS Health) in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Gattex (Teduglutide) Covered by Aetna (CVS Health) in Washington Aetna (CVS Health) requires prior authorization for Gattex (teduglutide) in short bowel syndrome patients dependent on parenteral nutrition ≥3 days/week for ≥12 months. Washington residents have strong appeal rights through the state's external review process

How to Get Tepezza (teprotumumab) Covered by Aetna CVS Health in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tepezza Approved by Aetna CVS Health in New Jersey Aetna CVS Health requires prior authorization for Tepezza (teprotumumab-trbw, J-code J3241) to treat moderate-to-severe thyroid eye disease in adults 18+. Coverage is limited to one lifetime course of 8 infusions over 24 weeks. First step: Have your ophthalmologist

How to Get Oxervate (cenegermin) Covered by Aetna (CVS Health) in Virginia: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Oxervate Covered by Aetna in Virginia Aetna (CVS Health) requires prior authorization for Oxervate (cenegermin) for neurotrophic keratitis. You'll need documented stage 2 or 3 disease (ICD-10 codes H16.231-H16.233), failure of artificial tears, and an ophthalmologist's prescription. Submit through CVS Caremark

How to Get Kanuma (Sebelipase Alfa) Covered by Aetna CVS Health in New Jersey: Complete Decision Tree & Appeals Guide

Quick Answer: Kanuma requires prior authorization from Aetna CVS Health for LAL-D treatment in New Jersey. You'll need confirmed enzyme deficiency (LAL activity testing) plus genetic confirmation (LIPA variants), clinical evidence of disease severity, and proper documentation. If denied, New Jersey's IHCAP external review through Maximus

Renewing Xenpozyme (Olipudase Alfa) Approval with Aetna CVS Health in Ohio: 2025 Requirements and Timeline

Answer Box: Renewing Xenpozyme Coverage in Ohio Start your Xenpozyme renewal 60-90 days before expiration to avoid treatment gaps. Aetna CVS Health requires updated clinical response data (spleen/liver volumes, platelet counts, chitotriosidase levels), continued ASMD diagnosis confirmation, and specialist attestation. First step today: Contact your metabolic specialist to schedule

How to Get Ibrance (Palbociclib) Covered by Aetna CVS Health in New Jersey: Complete Prior Authorization Guide

Quick Answer: Getting Ibrance (Palbociclib) Covered by Aetna CVS Health in New Jersey Ibrance requires prior authorization from Aetna CVS Health as a Tier 4/5 specialty drug for HR+/HER2- metastatic breast cancer. Your oncologist submits the PA with pathology confirming hormone receptor status, treatment history, and combination therapy